References
- Lowenstein SR, Gabow PA, Cramer J, et al. The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 1983: 143(10): 1882–5
- Staffurth JS, Gibberd MC, S Ng Tang Fui. Arterial embolism in thyrotoxicosis with atrial fibrillation. BMJ 1977: 2(6088): 688–90
- Kannel WB, Abbott RD, Savage DD, et al. Epidermiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982: 306(17): 1018–22
- Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978: 28(10): 973–7
- Orlando JR, van Herick R, Aronow WS, et al. Hemodynamics and echocardiograms before and after cardioversion of artial fibrillation to normal sinus rhythm. Chest 1979: 76(5): 521–6
- DeMaria AN, Lies JE, King JF, et al. Echocardiographic assessment of artial transport, mitral movement, and ventricular performance following electroversion of supraventicular arrhythmias. Circulation 1975: 51(2): 273–82
- Petersen P, Madsen EB, Burn B, et al. Silent cerebral infarction in chronic artial fibrillation. Stroke 1987: 18(6): 1098–100
- Morris JJ Jr, Peter RH, McIntosh HD. Electrical conversion artial fibrillation: immediate and long-term results and selection of patients. Ann Intern Med 1966: 65(Aug): 216–31
- Dittrich HC, Erickson JS, Schneiderman T, et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989: 63(3): 193–7
- Fenster PE, Comess KA, Marsh R, et al. Conversion of artial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 1983: 106(3): 501–4
- de Haas DD, Taliaferro EH, Amin NM. Intravenous procainamide for the conversion of new onset atrial fibrillation in the emergency department setting. J Emerg Med 1988: 6(3): 185–7
- Dunn M, Alexander J, de Silva R, et al. Antithrombotic therapy in atrial fibrillation. Chest 1989: 95(2 Suppl): 118–27S
- Goldman S, Probst P, Selzer A, et al. Inefficacy of “therapeutic” serum levels of digoxin in controlling the vertricular rate in atrial fibrillation. Am J Cardiol 1975: 35(5): 651–5
- Roth A, Harrison E, Mitani G, et al. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic artial fibrillation. Circulation 1986: 73(2)316–24
- Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989: 1(8631): 175–9
- Gurwitz JH, Goldberg RJ, Holden A, et al. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med 1988: 148(8): 1733–6
- Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 1984: 15(5): 779–89
- Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 1985: 254(24)3449–53
- Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lane atrial fibrillation: a population-based study over three decades. N Engl J Med 1987: 317(11): 669–74